68Ga-FAPI PET/CT 提高韦氏环扁桃体原发肿瘤检出
本研究纳入8例疑似韦氏环恶性肿瘤或CUP综合征患者,术前分别行18F-FDG与68Ga-FAPI-4 PET/CT,术后以病理和免疫组化对照。两种示踪剂均检出全部8例原发肿瘤,但68Ga-FAPI对健康对侧扁桃体摄取更低、TBRmax更高;小于7 mm的颈部淋巴结转移,18F-FDG检出率更高。
要点
- 68Ga-FAPI与18F-FDG均检出全部8例韦氏环原发肿瘤。
- 68Ga-FAPI对健康扁桃体摄取更低,TBRmax高于18F-FDG。
- 小于7 mm颈部淋巴结转移,18F-FDG检出率高于68Ga-FAPI。
核心结论
- 68Ga-FAPI PET/CT对CUP原发肿瘤的视觉检出优于18F-FDG,但淋巴结转移检出率较低。
研究设计与样本
- 纳入8例疑似韦氏环恶性肿瘤或CUP综合征患者,术前行18F-FDG与68Ga-FAPI-4 PET/CT,术后与病理及免疫组化对照。
主要发现
- 病理证实全部患者为扁桃体或舌根癌。
- 原发肿瘤平均SUVmax:18F-FDG为21.29 ± 7.97,68Ga-FAPI为16.06 ± 6.29(p = 0.2)。
- 健康对侧扁桃体平均SUVmax:18F-FDG为8.38 ± 2.45,68Ga-FAPI为3.55 ± 0.47(p < 0.001)。
- 68Ga-FAPI的SUVmax比值与18F-FDG显著不同(p = 0.03);68Ga-FAPI-4平均TBRmax为10.90,18F-FDG为4.11。
- 小于7 mm的颈部淋巴结转移,18F-FDG PET/CT检出率高于68Ga-FAPI PET/CT。
临床怎么用
- 对CUP综合征疑及韦氏环原发灶者,可考虑68Ga-FAPI PET/CT辅助定位原发肿瘤。
- 评估小淋巴结转移时需注意68Ga-FAPI检出率可能低于18F-FDG。
局限性
- 样本量仅8例,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In cancer of unknown primary (CUP), positron emission tomography/computed tomography (PET/CT) with the glucose analog [18F]FDG represents the standard imaging approach for localization of the malignant primary. Frequently, however, [18F]FDG PET/CT cannot precisely distinguish between small occult tumors and chronic inflammation, especially in Waldeyer's tonsillar ring. To improve the accuracy for detecting primary tumors in the Waldeyer's tonsillar ring, the novel PET tracer [68Ga]Ga-FAPI-4 for specific imaging of fibroblast activation protein (FAP) expression was used as a more specific target for cancer imaging. METHODS: Eight patients with suspicion of a malignant tumor in Waldeyer's tonsillar ring or a CUP syndrome were examined. PET/CT scans with [18F]-FDG and [68Ga]Ga-FAPI-4 were performed for pre-operative tumor localization. After surgical resection, histopathological and immunohistochemical results were compared to PET/CT findings. RESULTS: Histopathology revealed a palatine or lingual tonsil carcinoma in all patients. In case of lymph node metastases smaller than 7 mm in size, the [18F]FDG PET/CT detection rate of cervical lymph node metastases was higher than that of [68Ga]FAPI PET/CT, while both tracers identified the primary tumors in all eight cases. The size of the primary and the lymph node metastases was directly correlated to the respective FAP expression, as detected by immunohistochemistry. The mean SUVmax for the primary tumors was 21.29 ± 7.97 for 18F-FDG and 16.06 ± 6.29 for 68Ga-FAPI, respectively (p = 0.2). The mean SUVmax for the healthy contralateral tonsils was 8.38 ± 2.45 for [18F]FDG and 3.55 ± 0.47 for [68Ga]FAPI (p < 0.001). The SUVmax ratio of [68Ga]FAPI was significantly different from [18F] FDG (p = 0.03). Mean TBRmax for the [68Ga]Ga-FAPI-4 tracer was markedly higher in comparison to [18F]FDG (10.90 vs. 4.11). CONCLUSION: Non-invasive imaging of FAP expression by [68Ga]FAPI PET/CT resulted in a better visual detection of the malignant primary in CUP, as compared to [18F]FDG imaging. However, the detection rate of lymph node metastases was inferior, presumably due to low FAP expression in small metastases. Nevertheless, by offering a detection method for primary tumors with the potential of lower false positive rates and thus avoiding biopsies, patients with CUP syndrome may benefit from [68Ga]FAPI PET/CT imaging.
引用
- Serfling S, Zhi Y, Schirbel A, et al. Improved cancer detection in Waldeyer's tonsillar ring by 68Ga-FAPI PET/CT imaging. Eur J Nucl Med Mol Imaging. 2020. PMID: 33057927. doi:10.1007/s00259-020-05055-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。